Publication: 261

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 28 (22) 3617-3622
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
333   627  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, U10 CA032291, CA33601, CA 32291, CA47577, CA41287, U10 CA021115, U10 CA031946, CA77651, U10 CA033601, U10 CA017145, U10 CA045418, U10 CA077440, CA77440, CA17145, U10 CA041287, U10 CA047559, U10 CA077651, CA47559, CA45418, CA21115, CA31946  
Corr. Author:
 
Authors:
                               
Networks:
 
Study
CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Gic26, Original Reports, Gastrointestinal Cancer